EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Treatment patterns and visual acuity change of AMD patients, before, during and after the COVID ‐19 pandemic lockdowns: A large cohort

Dana Barequet iD, Reut Shor, Ori Segal, Eran Greenbaum, Omer Trivizki, Anat Loewenstein, Gilad Rabina iD

Acta Ophthalmologica · 2024

DOI: 10.1111/aos.15756 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Acta Ophthalmologica, 2024. Verfasst von Dana Barequet und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: COVID-19, Wet Macular Degeneration. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the impact of the changes in treatment patterns before, during and after the COVID‐19 pandemic on best‐corrected visual acuity (BCVA) in previously treated neovascular age‐related macular degeneration (nAMD) patients.

Methods

A multi‐centre, retrospective, observational study of consecutive nAMD patients during 2019–2021. Data collected included demographics, BCVA, dates of intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) injections and clinic visits.

Results

A total of 1652 eyes of 1652 nAMD patients were included, out of which 850 eyes were assessed in 2019 (pre‐COVID‐19), 630 eyes were assessed in 2020 (COVID‐19) and 974 eyes were assessed in 2021 (post‐COVID‐19). During the COVID‐19 period, the mean number of anti‐VEGF injections was significantly lower than the corresponding pre‐COVID‐19 and post‐COVID‐19 periods (5.55 compared to 6.13 and 6.60, respectively p < 0.01). A constant lower ratio of injections per patient/month was observed during COVID‐19 compared to previous and following years, with a notable decline during March–April, reaching a ratio of 0.4 in 2020 versus 0.65 in 2019 and 0.62 in 2021 ( p < 0.01). Baseline BCVA (0.825, p < 0.001), number of injections (−0.007, p < 0.001), gender (−0.027, p = 0.037) and age (0.004, p < 0.001) were shown to be significant predictors of final BCVA.

Conclusion

During the COVID‐19 period, patients were treated with significantly less intravitreal anti‐VEGF injection compared to the previous year with compensation in the following year. These changes in treatment patterns did not have a significant impact on BCVA outcomes. Age, gender, baseline BCVA and number of injections are predictors of final visual outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Wet Macular DegenerationHumansAngiogenesis InhibitorsVascular Endothelial Growth Factor ARetrospective StudiesPandemicsCommunicable Disease ControlIntravitreal InjectionsVisual AcuityRanibizumabTreatment OutcomeTomography, Optical Coherence

Stichwörter der Autor:innen

AMDCOVID 19anti‐VEGFlockdownneovascular AMD

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor ARanibizumab

Autor:innen und Institutionen

  • Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Department of Ophthalmology, Meir Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Kfar Saba, Israel.

ORCID-Profile: Dana Barequet, Gilad Rabina

Zitieren

APA

Barequet, D., Shor, R., Segal, O., Greenbaum, E., Trivizki, O., Loewenstein, A., & Rabina, G. (2024). Treatment patterns and visual acuity change of AMD patients, before, during and after the COVID ‐19 pandemic lockdowns: A large cohort. Acta Ophthalmologica. https://doi.org/10.1111/aos.15756

Vancouver

Barequet D, Shor R, Segal O, Greenbaum E, Trivizki O, Loewenstein A, et al. Treatment patterns and visual acuity change of AMD patients, before, during and after the COVID ‐19 pandemic lockdowns: A large cohort. Acta Ophthalmologica. 2024. doi:10.1111/aos.15756

BibTeX
@article{Barequet2024,
  author = {Barequet, Dana and Shor, Reut and Segal, Ori and Greenbaum, Eran and Trivizki, Omer and Loewenstein, Anat and Rabina, Gilad},
  title = {Treatment patterns and visual acuity change of AMD patients, before, during and after the COVID ‐19 pandemic lockdowns: A large cohort},
  journal = {Acta Ophthalmologica},
  year = {2024},
  doi = {10.1111/aos.15756}
}
Kostenlos starten →